ust as Mendelian genetics has been successful in identifying genes encoding transcription factors that define diseasecausing genetic networks, it seems likely that GWAS will succeed in defining a proportion of the binding sites for the same transcription factors in the enhancers and promoters of genes influencing liability to the common forms of related diseases. This was one of the major conclusions from the many discussion topics at our second Nature conference in China, the Genomic Analysis of Diseases Workshop (http://www.natureasia.com/ en/events/gad/). As with last year's meeting (Nat. Genet. 43, 613, 2011), we came away with recommendations for increasing the impact of publications in the journal-particularly by implementing ways in which the large number of new biological hypotheses produced by GWAS can be made more accessible to other investigators who may not yet be aware of their use and importance.
We note that, although basic common-variant GWAS papers reporting large numbers of new loci are still publishable, there is now an increasing emphasis on new biological insights into mechanisms of disease. Last year, it was still a live question whether different populations experience different subtypes of common diseases that might be explained by their particular genetic architecture or gene-environment interactions. Now, after a large number of studies (with most admittedly still in European and Asian populations), this idea has less support than the alternative-that common variants can differ in frequency and linkage disequilibrium structure in ways that influence their detection in GWAS in different populations.
As of June 2 of this year, GWAS has been applied to 666 diseases and traits in a total of 1,271 publications (http:// www.genome.gov/gwastudies/). Of these publications, 313 have appeared in this journal, reporting nearly half (1,891 out of 3,869) of the SNPs with an association P value of 5 × 10 -8 or lower. However, we are constantly reminded of the potential
